Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

New drug uses show promise but need more research.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

PP405 may help hair growth by activating hair follicle stem cells.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Phospholipids help plant proteins move by regulating receptor interactions.

PPARs help regulate skin health and could be used to treat skin disorders.

A peptide called DPS-1 helps human scalp cells grow and stimulates hair growth in mice.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Propranolol combined with injections caused skin changes in guinea pigs but didn't fully mimic psoriasis.